Risks of inadequate regulatory intelligence

6^th International Conference and Exhibtion on Pharmaceutical Regulatory Affairs and IPR

September 29-30, 2016 Orlando, USA

Priya Bhutani

RegDesk, Inc., USA

Scientific Tracks Abstracts: Pharmaceut Reg Affairs

Abstract :

Globalization coupled with an ever-changing regulatory/legislative landscape continues to increase the complexity of regulatory compliance. Regulatory Intelligence has become an essential tool in device/drug development, risk mitigation, and product lifecycle management. How are you improving the reliability of the intelligence you are gathering? How are you mitigating the risk of incorrect intelligence?

Biography :

Priya Bhutani is the CEO of RegDesk, Inc., US-based company. Priya has over 10 years experience in the MedTech industry. She holds an M.S. in Quality Assurance and Regulatory Sciences and another M.S. in Biomedical Engineering.

Email: priya@regdesk.co